Avoro Capital Advisors LLC Agenus Inc Transaction History

Avoro Capital Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$2.29 - $4.24 $6.3 Million - $11.7 Million	-2,750,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.92 - $4.39 $5.28 Million - $12.1 Million	2,750,000 New	2,750,000 $6.74 Million
Q2 2018 Aug 14, 2018	SELL	$2.26 - $4.65 $1.59 Million - $3.28 Million	-704,554 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$3.51 - $6.04 $6.09 Million - $10.5 Million	-1,735,000 Reduced 71.12%	704,554 $3.32 Million
Q4 2017 Feb 14, 2018	SELL	$3.26 - $4.78 $65,199 - $95,600	-20,000 Reduced 0.81%	2,439,554 $7.95 Million

Q3 2017 Nov 14, 2017	BUY	$3.48 - $4.44 $8.56 Million - $10.9 Million	2,459,554	2,459,554 $10.8 Million

128

205M

1.18M

69.8K

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.74B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Avoro Capital Advisors LLC with notifications on news.